Help revolutionize human health at CureVac

 

From day one, people have always been central to CureVac’s Mission – after all, we are on a mission to use therapeutic mRNA to transform people’s lives. That’s why we are dedicated to making CureVac a rewarding place to work for the people who help us get that much closer to making our mission a reality. And since our mission is no small one, we are looking for ambitious and passionate people who share our core values to join us in making a difference in the world.

  • "I started at CureVac in 2006 and I am proud to be one of the RNA people. We are not just developing new drugs but a completely new technology that is able to revolutionize medicine. And I have the opportunity to help that happen."

    Dr. Anita Buck, Senior Director IP Management
    Department: IP Management

  • "I've always wanted to make a difference in the world and make a positive contribution...here at CureVac I have the chance to do it.“

    Dr. Marion Pönisch, Senior Scientist
    Department: Molecular Therapy Research

  • "Working with a passionate team to overcome obstacles and further improve future medical treatments is rewarding, especially when improvements result in better treatments and benefit for patients.“

    Dr. Wolfgang Große, Scientist
    Department: Product Design & Formulation

  • "I am very excited to be part of CureVac and to help develop new therapeutic options against severe diseases. mRNA technology has the potential to revolutionize medicine and to be accessible to all. It is CureVac's spirit.“

    Dr. Frédéric Chevessier-Tünnesen, Associate Director Molecular Therapy
    Department: Molecular Therapy Research

"Ich freue mich sehr, ein Teil von CureVac zu sein und bei der Entwicklung neuer Therapiemöglichkeiten gegen schwere Krankheiten zu helfen. Die mRNA-Technologie hat das Potenzial, die Medizin zu revolutionieren und für alle zugänglich zu sein – das ist der Spirit von CureVac."

Dr. Frédéric Chevessier-Tünnesen, Associate Director Molecular Therapy
Department: Molecular Therapy Research